We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Allergic Diseases: Diagnosis and Management

M. Lawrence Podolsky, MD
JAMA. 1993;270(21):2623-2624. doi:10.1001/jama.1993.03510210109040.
Text Size: A A A
Published online


As a consequence of having reviewed the previous edition of this book in 1985, I was compelled to realize how fast and how far medicine has advanced in less than a decade and how well the authors have documented this progress in the sector of allergy. For instance, in his chapter "Biochemical Mediators of Allergic Reactions," Stephen I. Wasserman brings us up to date on exciting new developments that promise to revolutionize allergy: high molecular weight—neutrophil chemotactic activity (HMW-NCA), leukotrienes, cytokines, platelet-activating factor, arachidonic acid and its associated enzymes, 5-lipoxygenase and cyclooxygenase, and other chemotactic factors. Understanding that there are no clear-cut lines between practical and theoretical, research and dogma, conjecture and fact, and that there is no way of knowing just when a new development will become standard procedure, the authors prepare the groundwork for the "new allergy" of the future while keeping the book germane to the clinician


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.